Use of tolerance intervals for assessing biosimilarity

Chen, C; Hsiao, CF

Hsiao, CF (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.

STATISTICS IN MEDICINE, 2020; 39 (26): 3806

Abstract

A biosimilar is a biological product that is highly similar to an existing approved reference drug and has no clinically meaningful difference from it......

Full Text Link